605 related articles for article (PubMed ID: 21377506)
41. Structure of the biologically relevant G-quadruplex in the c-MYC promoter.
Yang D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):951-68. PubMed ID: 16901825
[TBL] [Abstract][Full Text] [Related]
42. Pyridyl-substituted corrole isomers: synthesis and their regulation to G-quadruplex structures.
Ma H; Zhang M; Zhang D; Huang R; Zhao Y; Yang H; Liu Y; Weng X; Zhou Y; Deng M; Xu L; Zhou X
Chem Asian J; 2010 Jan; 5(1):114-22. PubMed ID: 19937863
[TBL] [Abstract][Full Text] [Related]
43. Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands.
Kaulage MH; Maji B; Pasadi S; Ali A; Bhattacharya S; Muniyappa K
Eur J Med Chem; 2018 Mar; 148():178-194. PubMed ID: 29459277
[TBL] [Abstract][Full Text] [Related]
44. Fluorescent Dansyl-Guanosine Conjugates that Bind c-MYC Promoter G-Quadruplex and Downregulate c-MYC Expression.
Pavan Kumar Y; Saha P; Saha D; Bessi I; Schwalbe H; Chowdhury S; Dash J
Chembiochem; 2016 Mar; 17(5):388-93. PubMed ID: 26708259
[TBL] [Abstract][Full Text] [Related]
45. Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.
Cosconati S; Rizzo A; Trotta R; Pagano B; Iachettini S; De Tito S; Lauri I; Fotticchia I; Giustiniano M; Marinelli L; Giancola C; Novellino E; Biroccio A; Randazzo A
J Med Chem; 2012 Nov; 55(22):9785-92. PubMed ID: 23057850
[TBL] [Abstract][Full Text] [Related]
46. Ruthenium (II) polypyridyl complexes stabilize the bcl-2 promoter quadruplex and induce apoptosis of Hela tumor cells.
Wang C; Yu Q; Yang L; Liu Y; Sun D; Huang Y; Zhou Y; Zhang Q; Liu J
Biometals; 2013 Jun; 26(3):387-402. PubMed ID: 23543383
[TBL] [Abstract][Full Text] [Related]
47. Methylene blue as a G-quadruplex binding probe for label-free homogeneous electrochemical biosensing.
Zhang FT; Nie J; Zhang DW; Chen JT; Zhou YL; Zhang XX
Anal Chem; 2014 Oct; 86(19):9489-95. PubMed ID: 25211349
[TBL] [Abstract][Full Text] [Related]
48. DNA loop sequence as the determinant for chiral supramolecular compound G-quadruplex selectivity.
Yu H; Zhao C; Chen Y; Fu M; Ren J; Qu X
J Med Chem; 2010 Jan; 53(1):492-8. PubMed ID: 19911822
[TBL] [Abstract][Full Text] [Related]
49. Microwave-assisted synthesis of phenanthroimidazole derivatives as stabilizer of c-myc G-quadruplex DNA.
Liao S; Zhang Z; Wu Q; Wang X; Mei W
Bioorg Med Chem; 2014 Nov; 22(22):6503-8. PubMed ID: 25440731
[TBL] [Abstract][Full Text] [Related]
50. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure.
Jiang S; Awadasseid A; Narva S; Cao S; Tanaka Y; Wu Y; Fu W; Zhao X; Wei C; Zhang W
Life Sci; 2020 Oct; 258():118252. PubMed ID: 32791149
[TBL] [Abstract][Full Text] [Related]
51. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
Jin Y; Li H; Bai J
Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
[TBL] [Abstract][Full Text] [Related]
52. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
53. Silencing c-MYC expression by targeting quadruplex in P1 promoter using locked nucleic acid trap.
Kumar N; Patowary A; Sivasubbu S; Petersen M; Maiti S
Biochemistry; 2008 Dec; 47(50):13179-88. PubMed ID: 19053274
[TBL] [Abstract][Full Text] [Related]
54. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
[TBL] [Abstract][Full Text] [Related]
55. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
[TBL] [Abstract][Full Text] [Related]
56. A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences.
Costa G; Rocca R; Moraca F; Talarico C; Romeo I; Ortuso F; Alcaro S; Artese A
Mol Inform; 2016 Sep; 35(8-9):391-402. PubMed ID: 27546043
[TBL] [Abstract][Full Text] [Related]
57. New insights into the structures of ligand-quadruplex complexes from molecular dynamics simulations.
Hou JQ; Chen SB; Tan JH; Ou TM; Luo HB; Li D; Xu J; Gu LQ; Huang ZS
J Phys Chem B; 2010 Nov; 114(46):15301-10. PubMed ID: 21049896
[TBL] [Abstract][Full Text] [Related]
58. Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies.
Murat P; Bonnet R; Van der Heyden A; Spinelli N; Labbé P; Monchaud D; Teulade-Fichou MP; Dumy P; Defrancq E
Chemistry; 2010 May; 16(20):6106-14. PubMed ID: 20397247
[TBL] [Abstract][Full Text] [Related]
59. Methods for investigating G-quadruplex DNA/ligand interactions.
Murat P; Singh Y; Defrancq E
Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
[TBL] [Abstract][Full Text] [Related]
60. FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA.
Castillo-González D; Pérez-Machado G; Guédin A; Mergny JL; Cabrera-Pérez MA
Curr Pharm Des; 2013; 19(12):2164-73. PubMed ID: 23016840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
